FASENRA PEN

Google image searchProduct monograph

Active ingredient

benralizumab, 30 MG/ML

DIN: 02496135

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE USE PREFILLED AUTO-INJECTOR

Schedule: Prescription / Schedule D

Company: ASTRAZENECA CANADA INC

Date: 13-JAN-2021

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DX — Other systemic drugs for obstructive airway diseases (ATC, ATC/DDD)
• R03DX10 — BENRALIZUMAB (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Fasenra Pen

Search on Google

• Fasenra Pen side effects
• Fasenra Pen dosage
• benralizumab side effects
• benralizumab dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find fasenra pen photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.